))
FDA Drug Safety Podcast: Risk of serious and potentially fatal blood disorder prompts FDA action on oral over-the-counter benzocaine products used for teething and mouth pain and prescription local anesthetics
Archived series ("Inactive feed" status)
When?
This feed was archived on May 29, 2019 01:06 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 207334880 series 1381764
Content provided by U.S. Food, Drug Administration, and Center for Drug Evaluation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by U.S. Food, Drug Administration, and Center for Drug Evaluation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
On May 23, 2018, FDA warned that over-the-counter (or OTC) oral drug products containing benzocaine should not be used to treat infants and children younger than 2 years.
…
continue reading
12 episodes
Share
